Meredith M. Regan

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.329Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Development of a multi-institutional dataset to validate a novel inflammatory breast cancer diagnostic score

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf088

Top 52%

0.329DataRank

Top 52%7 citations

Samuel M. Niman, Megumi Kai, Sean G. Ryan, Elizabeth Troll, Li Li +16 more

Papers

Driven by 16 papers — median percentile 48. Top paper: “Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT”.

Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT

Journal of Clinical Oncology(2022)10.1200/jco.22.01065

N/A

2.2DataRank · unranked

59 citations

Gini F. Fleming, István Láng, Eva Ciruelos, Hervé Bonnefoi, Meritxell Bellet +22 more

Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer

Therapeutic Advances in Medical Oncology(2022)10.1177/17588359221113269

N/A

0.672DataRank · unranked

15 citations

Jennifer L. Guerriero, Sergey Naumenko, Shom Goel, Meredith M. Regan, Jiani Hu +10 more

Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009495

N/A

0.615DataRank · unranked

19 citations

Opeyemi A. Jegede, Elizabeth R. Plimack, Thomas Powles, Robert J. Motzer, Nizar M. Tannir +13 more

Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2283

N/A

0.609DataRank · unranked

57 citations

Opeyemi A. Jegede, Charlene M. Mantia, Thomas Powles, Lillian Werner, Robert J. Motzer +16 more

Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003743

N/A

0.542DataRank · unranked

36 citations

Charlene Mantia, Lillian Werner, Ahmad A. Tarhini, James Larkin, F. Stephen Hodi +10 more

Estimation of historical control rate for a single arm de-escalation study – Application to the POSITIVE trial

The Breast(2020)10.1016/j.breast.2020.05.012

N/A

0.442DataRank · unranked

18 citations

Samuel M. Niman, Olivia Pagani, Ann H. Partridge, Hatem A. Azim, Fedro A. Peccatori +6 more

Development of a multi-institutional dataset to validate a novel inflammatory breast cancer diagnostic score

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf088

Top 52%

0.329DataRank

Top 52%7 citations

Samuel M. Niman, Megumi Kai, Sean G. Ryan, Elizabeth Troll, Li Li +16 more

Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A)

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008293

N/A

0.292DataRank · unranked

6 citations

Opeyemi A. Jegede, Naomi B. Haas, David F. McDermott, Mehmet Asım Bilen, Mark N. Stein +11 more

A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1799

N/A

0.292DataRank · unranked

6 citations

Gary M. Clark, Charles A. Coltman, Mary L. Disis, S. Gail Eckhardt, Lee M. Ellis +21 more

Role of immunosuppressive JNK pathway in the tumor microenvironment among TNBC subtypes in IBCSG trial 22-00

iScience(2025)10.1016/j.isci.2025.112964

N/A

0DataRank · unranked

0 citations

Takashi Semba, Mattia Rediti, Daniel J. McGrail, Xuemei Xie, Xiaoping Wang +13 more

Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

The Lancet(2023)10.1016/s0140-6736(23)00285-4

N/A

0DataRank · unranked

195 citations

Rosie Bradley, Richard Gray, Robert K. Hills, Hongchao Pan, Richárd Pető +95 more

Genomic characterisation of hormone receptor-positive breast cancer arising in very young women

Annals of Oncology(2023)10.1016/j.annonc.2023.01.009

N/A

0DataRank · unranked

48 citations

Giuseppe Viale, Serena Nik‐Zainal, Peter Savas, Roswitha Kammler, Patrizia Dell’Orto +33 more

Treatment-free survival (TFS) outcomes from the phase II study of nivolumab and salvage nivolumab + ipilimumab in advanced clear cell renal cell carcinoma (aRCC) (HCRN GU16-260-Cohort A).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.604

N/A

0DataRank · unranked

5 citations

Opeyemi A. Jegede, David F. McDermott, Naomi B. Haas, Mehmet Asım Bilen, Mark N. Stein +11 more

Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial

Journal of Clinical Oncology(2024)10.1200/jco.24.00279

N/A

0DataRank · unranked

16 citations

Meredith M. Regan, Julia S. Stevens, David F. McDermott, Ravi A. Madan, David J. Einstein

Reply to B. Tombal et al

Journal of Clinical Oncology(2024)10.1200/jco-24-01595

N/A

0DataRank · unranked

0 citations

Meredith M. Regan, Julia S. Stevens, David F. McDermott, Ravi A. Madan, David J. Einstein

Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.40931

N/A

0DataRank · unranked

2 citations

Yue Ren, Yi Zhang, Natalia Siuliukina, Catherine A. Schnabel, Roswitha Kammler +27 more

Meredith M. Regan

Indexed papers

Top data-sharing exemplar

Papers